Free Trial

VolitionRx (VNRX) SEC Filings & 10K Form

VolitionRx logo
$0.66 +0.01 (+1.01%)
As of 11:15 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent VolitionRx SEC Filings

DateFilerForm TypeView
08/15/2025
4:16 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 10-Q/A
08/14/2025
8:43 PM
ARMISTICE CAPITAL, LLC (Filed by)
VOLITIONRX LTD (Subject)
VolitionRx (Subject)
Form SCHEDULE 13G/A
08/06/2025
8:00 AM
Reynolds Cameron John (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
8:00 AM
Innes Guy Archibald (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Rootsaert Rodney Gerard (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Forterre Gael (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Plummer Nicholas (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Batchelor Ann-Louise (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:01 PM
Reynolds Cameron John (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:01 PM
Hughes Terig (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
11:15 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form EFFECT
07/03/2025
1:17 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/03/2025
12:05 PM
Retter Andrew (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Butera Salvatore Thomas (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Batchelor Ann-Louise (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Forterre Gael (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Rootsaert Rodney Gerard (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:06 PM
Plummer Nicholas (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:27 AM
Reynolds Cameron John (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
6:55 AM
Innes Guy Archibald (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:05 PM
Hughes Terig (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Forterre Gael (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Butera Salvatore Thomas (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Rootsaert Rodney Gerard (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Michel Gaetan (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Plummer Nicholas (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Nguyen Kim (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:07 PM
Kway Jasmine (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
12:23 PM
Micallef Jacob Vincent (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
11:43 AM
Reynolds Cameron John (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
4:26 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
4:27 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2025
2:20 PM
ARMISTICE CAPITAL, LLC (Filed by)
VOLITIONRX LTD (Subject)
VolitionRx (Subject)
Form SCHEDULE 13G/A
04/22/2025
4:14 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 424B5
04/22/2025
4:16 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2025
11:15 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form EFFECT
04/16/2025
3:24 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form RW
04/15/2025
11:15 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form EFFECT
04/14/2025
8:39 AM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form S-3/A
04/04/2025
4:20 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/04/2025
4:22 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Overnight moves = possibly bigger returns (Ad)

Here’s a chart everyone should see that dates back to 1993… As you can see, the top line shows the much bigger average market return from trading overnight… Versus the bottom line, which shows the more modest average return from trading during the day. Look at that gigantic difference! So if you prefer nice big overnight returns instead, I agree with you. That’s why I’ve designed a breakthrough trade to tap into that overnight trading frenzy. You can check that out right here. Obviously, I won’t make any reckless guarantees in the stock market, but… That eye-opening chart above is just the beginning of the benefits you’ll see to trading overnight. PLUS, you’ll also see what my #1 ranked asset is in the entire market… And what my “hands-off” stocks are that I wouldn’t touch with a 100-foot pole.tc pixel

Check out the breakthrough overnight trade before I take the video down.
03/27/2025
7:13 AM
Innes Guy Archibald (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
7:13 AM
Reynolds Cameron John (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:11 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
8:02 AM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 424B5
11/14/2024
3:24 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
3:23 PM
STILL TIMOTHY I (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/30/2024
3:38 PM
Rubin Ethel (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:21 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:29 PM
Rubin Ethel (Reporting)
VOLITIONRX LTD (Issuer)
VolitionRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/27/2024
3:01 PM
VOLITIONRX LTD (Filer)
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:VNRX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners